Skip to content

Influence of the deqi sensation by suspended moxibustion stimulation in perennial allergic rhinitis: study for a multicenter prospective two arms cohort study based on propensity score regression adjustment (PSRA)

A prospective cohort study to explore moxibustion sensation and moxibustion efficacy in the treatment of perennial allergic rhinitis by moxibustion based on propensity score regression adjustment (PSRA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061597
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Experimental group:The deqi sensation by suspended moxibustion (Heat sensitive moxibustion)
Control group:The Non-deqi sensation by suspended moxibustion (Warm suspended moxibustion)

Sponsors

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the above diagnostic criteria; 2. Mild intermittent and mild persistent allergic rhinitis; 3. Aged between 18 and 60, with no gender limitation; 4. Participate in the clinical observation voluntarily and sign the informed consent; 5. Be able to obey the doctor's treatment arrangement and cooperate with the doctor's treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Complicated with serious cardiovascular, cerebrovascular, liver, kidney, hematopoietic, and other diseases; 2. There are other nasal diseases, such as chronic rhinitis, sinusitis, nasal polyps, nasal septum deviation, etc.; 3. Mental patients, pregnant or lactating women; 4. Annexing patients with upper respiratory diseases such as asthma and bronchitis; 5. People with acupuncture sickness, dizzy moxibustion or rejection of acupuncture and moxibustion.

Design outcomes

Primary

MeasureTime frame
Rhinitis symptom and sign score;Quality of life scale for rhino-conjunctivitis;SpecificIg E,sIgE;Interleukin 4, IL-4;T-helper 1,Th1;Interferon- ?,IFN- ?;Human eosinophilcationicprotein,ECP;

Secondary

MeasureTime frame
T-helper 2,Th2;

Countries

China

Contacts

Public ContactXiong Jun

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

xiongjun196071@163.com+86 13970054277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026